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ABBREVIATIONS
AED Antiepileptic drug
aEEG Amplitude-integrated electroen-
cephalography
Bayley-III Bayley Scales of Infant and
Toddler Development, Third
Edition
cEEG Continuous electroencephalog-
raphy
HIE Hypoxic–ischemic encephalopa-
thy
IQR Interquartile range
MSB Maximum seizure burden
ROC curve Receiver operator characteristic
curve
TSB Total seizure burden
AIM To examine the relationship between electrographic seizures and long-term outcome in
neonates with hypoxic–ischemic encephalopathy (HIE).
METHOD Full-term neonates with HIE born in Cork University Maternity Hospital from 2003 to
2006 (pre-hypothermia era) and 2009 to 2012 (hypothermia era) were included in this
observational study. All had early continuous electroencephalography monitoring. All
electrographic seizures were annotated. The total seizure burden and hourly seizure burden
were calculated. Outcome (normal/abnormal) was assessed at 24 to 48 months in surviving
neonates using either the Bayley Scales of Infant and Toddler Development, Third Edition or
the Griffiths Mental Development Scales; a diagnosis of cerebral palsy or epilepsy was also
considered an abnormal outcome.
RESULTS Continuous electroencephalography was recorded for a median of 57.1 hours
(interquartile range 33.5–80.5h) in 47 neonates (31 males, 16 females); 29 out of 47 (62%) had
electrographic seizures and 25 out of 47 (53%) had an abnormal outcome. The presence of
seizures per se was not associated with abnormal outcome (p=0.126); however, the odds of
an abnormal outcome increased over ninefold (odds ratio [OR] 9.56; 95% confidence interval
[95% CI] 2.43–37.67) if a neonate had a total seizure burden of more than 40 minutes
(p=0.001), and eightfold (OR: 8.00; 95% CI: 2.06–31.07) if a neonate had a maximum hourly
seizure burden of more than 13 minutes per hour (p=0.003). Controlling for electrographic
HIE grade or treatment with hypothermia did not change the direction of the relationship
between seizure burden and outcome.
INTERPRETATION In HIE, a high electrographic seizure burden is significantly associated with
abnormal outcome, independent of HIE severity or treatment with hypothermia.
Hypoxic–ischemic encephalopathy (HIE) is a common
cause of seizures in term neonates. In HIE, seizures signal
the secondary injury phase and may further aggravate brain
damage.1–3 Numerous studies in asphyxiated neonates
before the advent of therapeutic hypothermia have shown a
relationship between the presence of clinical and electro-
graphic seizures, especially status epilepticus, and an
abnormal outcome.2,4–7 Most of these studies used clinical
assessment or amplitude-integrated electroencephalography
(aEEG) for seizure detection and quantification. In addi-
tion, many assessed only short-term outcome, analysed
cohorts of mixed aetiology, or did not control for con-
founding variables. Owing to the difficulty of separating
the severity of the underlying injury from the effect of sei-
zures themselves, debate persists about the impact of sei-
zures on brain injury and outcome.8,9
The advent of therapeutic hypothermia has inspired
researchers to re-evaluate the relationship between seizures
and outcome, as therapeutic hypothermia has been shown
to reduce total seizure burden (TSB)10 and improve out-
comes in HIE.11 Several studies in neonates with HIE
undergoing hypothermia have shown that electrographic
seizures and high seizure burden are associated with more
severe brain injury on magnetic resonance imaging
(MRI).12–14 In a recent randomized anti-seizure treatment
trial in neonates with HIE, most of whom were treated
with hypothermia, a higher TSB on continuous electroen-
cephalography (cEEG) was associated with lower scores on
the Bayley Scales of Infant and Toddler Development,
Third Edition (Bayley-III) at 18 to 24 months of age. The
results were not controlled for HIE severity or therapeutic
hypothermia, and hourly seizure burdens were not quanti-
fied.14
We used cEEG to examine the relationship between
neonatal seizures, seizure burden, and developmental out-
come at 24 to 48 months of age in neonates with mod-
erate and severe HIE treated and not treated with
hypothermia.
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METHOD
Patients
This study included neonates at more than and including
37 weeks’ gestation, born in Cork University Maternity
Hospital in 2003 to 2006 (pre-hypothermia era) and in
2009 to 2012 (hypothermia era), who fulfilled the criteria
of perinatal asphyxia and who had clinical signs of evolving
HIE (mild, moderate, and severe).4 We excluded neonates
with evidence of perinatal infection, metabolic or congeni-
tal abnormalities. This study was a retrospective analysis of
two cohorts of neonates prospectively recruited to cEEG
studies of neonates at high risk of seizures.4,15 The modi-
fied Sarnat score (Levene) for HIE was performed in all
neonates at 24 hours after birth during recruitment of both
studies.
cEEG recordings and HIE grading
All neonates underwent video-cEEG monitoring (Nicolet
One ICU Monitor, Neuro-Care; Carefusion, Middleton,
WI, USA) with active electrodes applied at F3, F4, C3,
C4, T3, T4, O1, O2, and Cz (international 10–20 system
of electrode placement modified for neonates), with single-
channel electrocardiography and respiration monitoring.
The aEEG signal was displayed simultaneously. cEEG
recordings were reviewed retrospectively in their entirety
by an experienced neonatal neurophysiologist (GBB).
The overall severity of HIE was determined electro-
graphically at 24 hours after birth on the basis of cEEG
background characteristics, presence of sleep–wake cycle,
and electrographic seizures (Table I).4 The electrographic
grading of HIE severity was selected as a less subjective
method over clinical HIE grading.11 Neonates with mildly
or moderately abnormal cEEG background patterns were
considered to have mild or moderate electrographic HIE
grades respectively; neonates with majorly abnormal or
inactive patterns were combined into one group designated
as a severe electrographic HIE grade. If the cEEG was
graded as mildly abnormal at 24 hours after birth but elec-
trographic seizures were present at any time, the cEEG
recording received a moderate electrographic grade of
HIE. In our analysis, we excluded all neonates with a mild
electrographic HIE grade at 24 hours after birth. We also
excluded cases where monitoring was initiated beyond
24 hours of birth or if monitoring was less than 24 hours
in total duration.
Seizure analysis and quantification
All seizures in each entire cEEG recording were annotated
visually. Electrographic seizure was defined as a sudden
repetitive, stereotyped discharge of minimum 10 seconds’
duration on one or more EEG channels with evolving fre-
quency, amplitude, and morphology.16 The annotations
were used to calculate TSB and hourly seizure burden for
each neonate. Following this analysis, two summary mea-
sures of seizures over different time scales were defined:
TSB and maximum seizure burden (MSB). The TSB sum-
marizes the duration of all seizures on the EEG recording
Table I: Clinical characteristics of neonates with normal and abnormal outcome included in the study (n=47)
Normal outcome (n=22)a Abnormal outcome (n=25)a
pbn % n %
Sex
Male 13 59.1 18 72.0 0.376
Female 9 40.9 7 28.0
Clinical Sarnat HIE grade
Mild 5 22.7 2 8.0 0.018
Moderate 14 63.6 10 40.0
Severe 3 13.6 13 52.0
cEEG-HIE grade
Moderate 18 81.8 6 24.0 <0.001
Severe 4 18.2 19 76.0
Therapeutic hypothermia status
Therapeutic hypothermia 13 59.1 7 28.0 0.042
Non-therapeutic hypothermia 9 40.9 18 72.0
Number of AEDsc,d
<3 21 95.5 9 37.5 <0.001
≥3 1 4.5 15 62.5
Median IQR Median IQR pe
Gestational age (wk) 40.7 38.9–41.1 40.5 39.7–41.6 0.536
Birthweight (g) 3500 3163–3910 3450 3045–3815 0.991
Apgar at 5minc 5 4–6 5 2–7 0.807
aUnless otherwise stated. bFrom Fisher’s exact test. cn=24 for abnormal outcome group. dThirty-one neonates in the cohort received AED.
eFrom Mann–Whitney U test. cEEG, continuous electroencephalography; HIE, hypoxic–ischemic encephalopathy; AED, antiepileptic drug;
IQR, interquartile range.
What this paper adds
• In hypoxic–ischemic encephalopathy (HIE), high electrographic seizure burden
is significantly associated with abnormal outcome.
• The association is independent of HIE severity or treatment with
hypothermia.
• The presence of seizures per se is not associated with abnormal outcome.
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for each patient individually and is measured in minutes.
The MSB is defined as the maximum hourly seizure bur-
den within cEEG recording and is measured in minutes
per hour.
Seizure period was also calculated as the time from the
onset of the first electrographic seizure to the offset of the
last electrographic seizure.
Administration of antiepileptic drugs (AEDs) was
recorded and included phenobarbitone as first-line medica-
tion, followed by phenytoin and midazolam as second- and
a third-line medications respectively. Lidocaine and leve-
tiracetam were also used in refractory cases.
The antiepileptic protocols and general treatment,
besides therapeutic hypothermia, did not differ between
the two periods (pre-hypothermia and hypothermia eras).
All clinical seizures in the cohort were treated. Neonatolo-
gists used the aEEG display to aid seizure treatment deci-
sions when necessary. Immediate cEEG interpretation was
not always available, but, in the case of suspected seizures
on aEEG or clinical seizures, the cEEG was interpreted by
encephalographers as soon as possible and all seizures
detected were treated.
Outcome
Neurodevelopmental outcome was assessed using either
Bayley-III (by CEA) or the Griffiths Mental Development
Scales (by DMM) at the age of 24 to 48 months. The
assessors were blind to the neonatal clinical course and
cEEG findings. Griffiths assessment was performed in the
cohort recruited between 2003 and 2006 (Murray et al.4)
and in neonates recruited in 2009 to 2012 who were older
than 42 months at the time of the assessment.
The outcome was graded as binary (normal/abnormal).
We considered outcome as abnormal in the case of death,
dyskinetic or spastic quadriplegic CP, epilepsy diagnosed
by a paediatric neurologist, a Griffiths general quotient
(GQ) <87, or more than two SDs below the mean in any
individual subquotient; and a Bayley-III composite score
<85 in all three subscales or <70 in any individual subscale.
Statistical analysis
Statistical analysis was performed using IBM SPSS Statis-
tics (version 22.0; IBM Corp., Armonk, NY, USA). Con-
tinuous variables were described using median
(interquartile range [IQR]) and categorical data using fre-
quency (%). For comparisons between groups, the Mann–
Whitney U test was used for continuous variables and
Fisher’s exact test for categorical variables. The association
between TSB, MSB, and outcome was assessed using recei-
ver operator characteristic (ROC) curve analysis. Optimal
cutoff points of TSB and MSB were chosen as the point
on the ROC curve closest to the upper left corner (where
sensitivity=1 and specificity=1), often known as the (0,1)
criterion. Diagnostic accuracy was assessed using positive
predictive value, negative predictive value, and area under
the ROC curve and their corresponding 95% confidence
intervals (CIs). Univariable and multivariable logistic
regression analyses estimated unadjusted and adjusted odds
ratios (OR) and 95% CIs of an abnormal outcome. All
tests were two-sided and a p-value <0.05 was considered to
be statistically significant.
Ethical approval
The clinical Research Ethics Committee of the Cork
Teaching Hospitals approved this study. Written informed
consent was obtained from the parents of all children stud-
ied. Patient data were anonymized before analysis.
RESULTS
During the recruitment periods, cEEG was recorded in
100 neonates with HIE. The electrographic HIE grade at
24 hours was mild in 40, moderate in 32, and severe in 28.
Of these, 53 neonates were excluded: 40 neonates had a
mild cEEG grade; in six neonates the cEEG recording
started beyond 24 hours of birth or was less than 24 hours
in duration; and seven neonates were lost to follow-up.
This resulted in a study cohort of 47 neonates: 24 with
moderate HIE (15 non-therapeutic hypothermia and 9
therapeutic hypothermia) and 23 with severe HIE (12 non-
therapeutic hypothermia and 11 therapeutic hypothermia).
Clinical characteristics are presented in Table I.
cEEG monitoring was started at a median age of
6 hours after birth (IQR 3.5–11.0) and continued for a
median of 57.1 hours (IQR 33.5–80.5). Twenty-nine out
of 47 neonates had electrographic seizures. Seizure charac-
teristics in relation to therapeutic hypothermia subgroups
are shown in Table II.
In the cohort, 31 neonates received AEDs. Seven neo-
nates were treated with AEDs for suspected clinical sei-
zures before cEEG monitoring and/or during cEEG
monitoring without further confirmation of electrographic
seizures. Thirteen out of 31 neonates received AEDs
before cEEG monitoring initiation (five in the therapeutic
hypothermia subgroup [n=2 were seizure free] and eight in
the non-therapeutic hypothermia subgroup [n=2 were sei-
zure free]). Four neonates with electrographic seizures did
not receive AEDs.
An abnormal outcome was seen in 25 out of 47 neo-
nates: seven infants died (five neonates with severe
encephalopathy died during the early neonatal period, and
two infants with severe spastic quadriplegia died at 4
months and 24 months of age after recurrent respiratory
infections); five of those who died had electrographic sei-
zures; 12 other patients survived with CP (10 seizure and
two non-seizure), and six further infants had abnormal
Bayley-III (n=2, one seizure and one non-seizure) or Grif-
fiths assessments (n=4, two with seizures and two without
seizures).
Five out of 40 survivors developed epilepsy (all five were
from the group with CP and had electrographic seizures).
The severity of HIE grade at 24 hours after birth and the
absence of treatment with therapeutic hypothermia were
significantly associated with abnormal outcome at 24 to
48 months (p<0.001 and p=0.042 respectively; Table I).
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Assessment of seizures and outcome
The percentage of infants with an abnormal outcome was
higher in the seizure group: 62% (18 out of 29) compared
with 39% (7 out of 18) in the non-seizure group; however,
this difference did not reach statistical significance
(p=0.126; Table III).
Assessment of seizure burden and outcome in the cohort
TSB was significantly higher in neonates with an abnormal
outcome (median [IQR] 151.60 [0–225.85] min, n=25) than
in neonates with a normal outcome (median [IQR] 2.35
[0–28.60] min, n=22, p=0.002). MSB was also significantly
higher in the group with an abnormal outcome (median
[IQR] 25.10 [0–45.60] min/h) than in the group with a
normal outcome (median [IQR] 2.35 [0–11.95] min/h,
p=0.002). Based on the ROC curve analysis, the optimal
cut-off point to predict abnormal outcome was 40 minutes
for TSB and 13 minutes per hour for MSB.
A TSB of more than 40 minutes (high TSB) (n=21) and
an MSB of more than 13 minutes per hour (high MSB)
(n=20) significantly increased the risk of the abnormal out-
come (p=0.001 and p=0.003 respectively). This increase was
independent of the electrographic grade of HIE at
24 hours after birth or the application of therapeutic
hypothermia (Table III).
The area under the ROC curve was 0.75 (95% CI 0.60–
0.86) for a high TSB and 0.73 (95% CI 0.57–0.84) for a
high MSB. The positive predictive value of a high TSB for
abnormal outcome was 81%, while the negative predictive
value was 69%. A high MSB had a positive predictive value
of 80% and a negative predictive value of 67%.
In the whole cohort, 18 neonates had both a high TSB
and a high MSB, and in 16 out of 18, the outcome was
abnormal. In addition, five out of seven neonates who died,
10 out of 12 neonates with CP, and all five neonates with
later epilepsy had either high TSB or both high TSB and
high MSB.
Assessment of seizure burden and outcome in the seizure
subgroup (29 neonates)
In the subgroup of neonates with seizures, the median
TSB and MSB remained significantly higher in those with
an abnormal outcome (p<0.001 for both; Table IV and
Fig. 1). For every 1-minute increase of TSB, the odds of
the abnormal outcome increased by 2.2% (OR 1.022; 95%
CI 1.005–1.039, p=0.011) and for every 1-minute increase
of MSB the odds of the abnormal outcome increased by
16% (OR 1.16; 95% CI 1.04–1.30, p=0.008). Neonates
with abnormal development had significantly longer sei-
zure periods (p=0.002), reflecting the increase in seizure
Table II: Seizure characteristics in neonates treated with and without therapeutic hypothermia in the cohort (n=47)
Non-therapeutic hypothermia
(n=27)a
Therapeutic hypothermia
(n=20)a
pbMedian IQRa Median IQRa
Start of recording (h after birth) 10.2 4.9–14.0 3.8 3.3–6.0 0.002
Duration of EEG recording (h) 37.2 25.7–55.6 82.0 76.5–92.0 <0.001
Seizure frequency: n (%) 17 63.0 12 60.0 1c
Seizure frequency in moderate HIE: n (%) 8/15 53.3 3/9 33.3 0.423c
Seizure frequency in severe HIE: n (%) 9/12 75.0 9/11 81.8 1c
Seizure onset (h after birth)d 15.3 11.6–21.3 13.7 11.7–18.4 0.711
Time of MSB (h after birth)d 19.6 17.3–29.4 17.3 15.0–21.8 0.211
Seizure period (h)d 33.2 13.0–46.0 14.0 6.3–37.0 0.283
TSB (min)d 183.2 45.1–311.3 55.8 22.4–145.2 0.097
TSB in moderate HIE (min)d 87.9 11.8–197.4 24.1 21.8–118.9e 0.497
TSB in severe HIE (min)d 206.1 144.4–510.1 67.2 28.5–176.1 0.019
MSB (min/h)d 25.1 12.6–47.0 18.5 9.6–33.3 0.419
MSB in moderate HIE (min/h)d 12.6 7.8–33.4 21.8 8.6–30.2e 1
MSB in severe HIE (min/h)d 45 22.7–50.8 15.2 10.1–38.5 0.094
aUnless otherwise stated. bFrom Mann–Whitney U test unless otherwise stated. cFrom Fisher’s exact test. dSeizure infants only. eMinimum
to maximum as n=3. IQR, interquartile range; EEG, encephalography; HIE, hypoxic–ischemic encephalopathy; MSB, maximum seizure
burden TSB, total seizure burden.
Table III: Logistic regression analysis showing relationships between seizures, high total seizure burden (TSB; >40min), high maximum seizure burden
(MSB; >13min/h), and abnormal outcome (n=47)
Unadjusted Adjusted for cEEG-HIE grade
Adjusted for therapeutic
hypothermia
OR 95% CI p OR 95% CI p OR 95% CI p
Seizure (n=29) 2.57 0.77–8.61 0.126 1.25 0.28–5.55 0.769 2.74 0.76–9.88 0.123
TSB >40min (n=21) 9.56 2.43–37.67 0.001 4.84 1.04–22.65 0.045 11.42 2.51–51.99 0.002
MSB >13min (n=20) 8.00 2.06–31.07 0.003 5.57 1.18–26.28 0.030 8.21 1.96–34.42 0.004
cEEG, multi-channel electroencephalogram; HIE, hypoxic–ischemic encephalopathy; OR, odds ratio; 95% CI, 95% confidence interval.
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burden. The MSB was significantly later after birth in the
abnormal outcome group (p=0.024) (Table IV).
DISCUSSION
In our cohort of 47 infants with electrographically con-
firmed moderate or severe HIE, the presence of seizures
alone was not associated with abnormal outcome at 24 to
48 months; however, a TSB of more than 40 minutes and
an MSB of more than 13 minutes per hour were associated
with a significantly higher risk of abnormal development,
independent of the application of therapeutic hypothermia
or electrographic HIE grade at 24 hours after birth.
In the unadjusted analysis of the subgroup of neonates
with seizures (n=29), the median TSB and MSB in neonates
with abnormal development remained significantly higher.
These results indicate that, in HIE, a high accumulation
of seizures plays a more significant role for long-term devel-
opmental outcome than the presence of seizures per se.17
The existing physiological evidence from numerous clin-
ical and preclinical studies may help to explain why a high
seizure burden increases neurological deficit after HIE.
Neonatal seizures have been shown to cause acute local
energy depletion, alteration of cerebral blood flow and
nutrient supply, and to induce neuronal disintegration.2,3
Seizure propagation, and rapid or prolonged accumulation
of seizures, results in more significant energy depletion
and subsequent apoptosis.1
Increased apoptosis and impaired neurogenesis after pro-
longed neonatal seizures have been reported in animal mod-
els of hypoxia.18 Recurrent neonatal seizures in rodents were
linked to the formation of excessive excitatory circuits in the
hippocampus and later epilepsy.19 A pathophysiological cas-
cade initiated by prolonged or recurrent seizures may con-
tribute to persistent neuronal inflammation,1 which has been
proposed as an important mechanism in the pathogenesis of
CP.20 In our cohort, 10 of the 12 neonates who survived
with CP, and all five neonates who subsequently developed
epilepsy, had either a high TSB or MSB.
Before the advent of therapeutic hypothermia, studies
demonstrated contradictory findings between the presence
of seizure and outcome,6,8,9 although status epilepticus,
defined as seizure burden of more than 20 to 30 minutes
per hour, was consistently shown to be associated with
unfavourable long-term and short-term outcomes.5,6,21
The importance of neonatal seizure burden for outcome
has been highlighted by many researchers,2,7,9,22 but in
HIE it has not been fully quantified for long-term out-
come.7,12,14 In critically ill children with diseases of mixed
aetiologies, including neonates with HIE, MSB of more
than 12 minutes per hour was found to be associated with
an increase in short-term neurological decline, independent
of the diagnosis or severity of illness.22 We have shown
that, in HIE, an MSB of more than 13 minutes per hour is
associated with poor long-term outcome, which is conspic-
uously less than the traditional definition of status epilepti-
cus (seizure burden ≥30min/h)23 and slightly less than the
threshold of 15 minutes per hour confirmed for aEEG sei-
zures in relation to greater cerebral injury on MRI in a
cooled HIE cohort.12
Therapeutic hypothermia decreases overall neuronal
excitability and seizure propagation, downregulates cerebral
metabolism and inflammation, and reduces cerebral necrosis
and apoptosis.1 However, current protocols for therapeutic
Table IV: Seizure characteristics of neonates with normal and abnormal
outcomes in the seizure subgroup (n=29)
Normal outcome
(n=11)
Abnormal outcome
(n=18)
paMedian IQR Median IQR
TSB (min) 25.4 14.8–78.20 198.7 96.0–390.8 <0.001
MSB (min) 11.7 7.3–15.2 35.3 23.8–48.3 <0.001
Seizure onset
(h after
birth)
13.2 10.2–15.3 16.7 12.6–20.9 0.173
Seizure
period (h)
10.3 0.4–15.6 35.3 18.2–53.0 0.002
MSB (h after
birth)
16.9 14.4–22.0 20.4 18.2–32.3 0.024
aFrom Mann–Whitney U test. IQR, interquartile range; TSB, total
seizure burden; MSB, maximum seizure burden.
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Figure 1: Increased seizure burden in neonates with abnormal neurodevelopmental outcome in the seizure subgroup (n=29). (a) Total seizure burden
(TSB) in neonates with normal and abnormal outcomes, Mann–Whitney U test, p<0.001. (b) Maximum seizure burden (MSB) in neonates with normal
and abnormal outcomes, Mann–Whitney U test, p<0.001.
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hypothermia are more effective in moderate than severe
encephalopathy,1 and the TSB is significantly reduced in
neonates undergoing therapeutic hypothermia with clini-
cally moderate but not severe HIE.10 In HIE cohorts with
hypothermia, seizures on cEEG were associated with more
severe structural brain damage, although 40% of neonates
with seizures may have a normal MRI.13,14
Our findings suggest that a high seizure burden is associ-
ated with an abnormal outcome, irrespective of therapeutic
hypothermia. While therapeutic hypothermia reduces sei-
zure burden, the reduction in some neonates may not be suf-
ficient to significantly improve outcome.1 Future advances
in therapeutic hypothermia protocols may enhance neuro-
protective and antiepileptic effects of hypothermia. Clearly,
further research is needed to improve AEDs for neonates to
help reduce seizure burden in HIE.
The difference in TSB between our neonates treated
with therapeutic hypothermia and those without therapeu-
tic hypothermia was dramatic in absolute figures (median
55.8min vs 183.2min), but did not reach statistical signifi-
cance in the group overall, owing to the high variability
in seizure burden across neonates. However, the overall
trend for lower seizure burden in our neonates undergo-
ing hypothermia remained, and in our hypothermic sub-
group with severe HIE the TSB was significantly lower.
The detrimental effect of a high seizure burden on out-
come in our cohort was also independent of the severity of
HIE assessed electrographically at 24 hours after birth.
Unfortunately, the size of our cohort did not allow for simul-
taneous control for therapeutic hypothermia and HIE grade.
This is a retrospective study and, as such, the sample
size was limited to the number of neonates with moderate
and severe HIE collected in the study periods; confidence
intervals for the parameters of interest were wide.
Neuroimaging was not available for most of the non-
therapeutic hypothermia cohort; therefore, further evalua-
tion of structural brain injury was not possible. MRI assists
in the prediction of the severity and type of neurodevelop-
mental delay;17 however, electrographic grade of HIE has
been shown to be as useful as MRI for evaluating the
severity of brain injury after perinatal asphyxia.4,17
We assessed motor, language, and cognitive function at
24 to 48 months. Motor disability, or general severe dis-
ability in HIE, are usually correctly diagnosed by 2 years
of age,24 while the assessment of cognitive skills and beha-
viour is more accurate at 6 to 7 years.25
Also, children were assessed using two different methods
of outcome assessment (Griffiths and Bayley-III scales),
which are not directly comparable. However, both meth-
ods provided a validated structured neurodevelopmental
assessment.
A large proportion of our neonates received AEDs during
their clinical course. A similar number of neonates from our
hypothermic and normothermic cohorts were treated with
AEDs, but neonates treated with therapeutic hypothermia
more frequently received one AED, while neonates not trea-
ted therapeutic hypothermia received three or more AEDs.
This most probably reflects the increased seizure burden in
the non-therapeutic hypothermia group.10 The potential
effects of AEDs on seizure burden and EEG background
were not analysed in our cohort.
Finally, cEEG monitoring in the non-therapeutic
hypothermia group was less prolonged, and therefore some
seizures in this group might have been missed, although
their TSB was higher and the length of cEEG in our
cohort was sufficient to detect most seizures.12,13
Despite limitations, this study expands our knowledge
about the relationships between neonatal electrographic
seizures and long-term outcome in HIE, and attempts to
control for the severity of injury and the application of
therapeutic hypothermia.
CONCLUSION
In infants with moderate and severe HIE, a high electro-
graphic seizure burden is significantly associated with
abnormal outcome at 24 to 48 months, independent of the
severity of encephalopathy or treatment with hypothermia.
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